Previous Next Accountability Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price Abstract: Critics say the government deserves more credit for tens of millions in public money spent to develop the coronavirus treatment. Publication: The Washington Post Date Published: May 26, 2020 Author(s): Christopher Rowland View This Resource